Knightscope Inc Ordinary Shares - Class A KSCP 深 滬
等待開盤 12-12 09:30:00 美东时间
5.00
+0.570
+12.87%
華盛通- 最 高5.1081
- 今 開4.84
- 成交量 88.45万股
- 最 低 4.66
- 昨 收 4.43
- 總市值 3450.60万
- 52周最高 17.7877
- 市盈率 靜 --
- 換手率 12.82%
- 52周最低 2.45
- 委 比 -40.20%
- 總股本 690.12万
- 歷史最高 1375.00
- 量 比 2.55
- 振 幅 10.12%
- 歷史最低 2.45
- 每 手 1
- 風險率 2.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
今天 10:24
Ascendiant Capital Maintains Buy on Knightscope, Lowers Price Target to $25
Ascendiant Capital analyst Edward Woo maintains Knightscope (NASDAQ:KSCP) with a Buy and lowers the price target from $27 to $25.
12-11 17:31
Peering Into Knightscope Inc's Recent Short Interest
Knightscope Inc's (NYSE:KSCP) short interest as a percent of float has risen 28...
11-26 02:00
Knightscope Unveils the All-New K7 Autonomous Security Robot
Sunnyvale, California, November 13th, 2025, FinanceWire Knightscope, Inc. (NASD...
11-14 00:00
Knightscope Q3 EPS $(0.98) Misses $(0.78) Estimate, Sales $3.131M Beat $2.873M Estimate
Knightscope (NASDAQ:KSCP) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.78) by 25.16 percent. This is a 72.63 percent increase over losses of $(3.58) per share from the
11-13 19:13
Knightscope Hits Another $1M Milestone In New Contracts And Client Renewals
Knightscope, Inc. (NASDAQ:KSCP), a leading developer of advanced physical security technologies, today announced that it has achieved another $1 million milestone in new contracts and client renewals. Following similar
11-12 22:43
Knightscope Announces It Has Exceeded Yet An Additional $1M In New Contracts And Renewals
Knightscope, Inc. (NASDAQ:KSCP), a leader in autonomous security robots and emergency communication devices, on the heels of announcing $1 million last month and months prior, today announced that it has exceeded yet an
10-14 21:22
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
Ascendiant Capital Maintains Buy on Knightscope, Raises Price Target to $27
Ascendiant Capital analyst Edward Woo maintains Knightscope (NASDAQ:KSCP) with a Buy and raises the price target from $26 to $27.
10-06 18:25
Knightscope Inc. Elects Directors and Approves Proposals
Knightscope Inc Class A ( ($KSCP) ) has shared an announcement. On September 8,...
09-10 05:50
